Cardiometabolic Medicine
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia. These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
Analyzing Safety Data for siRNA for Lowering LDL-C and Lp(a)
Recent Advances in Risk Assessment in Patients with Hyperlipidemia: Enhancing Precision and Reliability
2) This presentation was originally delivered by @NP_ltl_a at an accredited satellite symposium at @nationallipid's June 2023 congress. She...
Comparing In-Hospital Mortality with Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate
1b) Follow this 🧵to earn 0.5hr 🆓 CE/#CME on your only source for expert-authored #MedEd in the #cardiometabolic space delivered wholly on X--or...
Understanding the Limitations and Inconveniences of Current Approaches to CAT Management
2) The program is supported by an unrestricted educational grant from Anthos Therapeutics. Statement of accreditation & faculty disclosures at...
ESC2023 LATE-BREAKING CLINICAL TRIAL UPDATES ON ADVANCES IN MANAGEMENT OF HYPERLIPIDEMIA IN STATIN-INTOLERANT & STATIN-REFRACTORY PATIENTS
1b) @ProfKausikRay will particularly focus on data for non-#statin #LLT from #ESCCongress, following on the heels of the presentation of the primary...
Guidelines and Recent Data: Developing Optimal Treatment Plans for Patients with PAH
2) This program is supported by an unrestricted educational grant from Bayer. Statement of accreditation & faculty disclosures at...
Anemia of CKD: Pathophysiology
2) Follow this 🧵for your credit!Statement of accreditation and faculty disclosures are at https://t.co/gvXca4G9Xm. This program is intended for...
Expert Discussion at ISTH 2023: Improving the Effectiveness of Anticoagulant Therapy: The Promise of Factor XI Inhibition
2) The expert faculty for this session were @ShaunGoodman, @connors_md, @MellanieHills of @stopafib, & the inimitable #JeffWeitzMD. Learning...
HCM: What Non-Specialists Should Know, and What Interventional Cardiologists Should Worry About
2) This program is intended for #HCPs & is supported by an unrestricted educational grant from Bristol Myers Squibb. Statement of accreditation...
Update on Experience with Novel, Patient-Administered Therapy for for PSVT
1b) Our faculty are esteemed 🇬🇧 cardiologist John Camm @johncamm, #EiC @Clin_Cardiology, Past President #EHRA, along with #emergencymedicine...
@Cardiomet_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.